PDF(Pubmed)
Abstract：
Percutaneous endoscopic cecostomy (PEC) is a viable treatment option for patients with persistent or recurrent acute colonic pseudo-obstruction (ACPO; Ogilvie\'s syndrome). It should be generally considered in patients that are refractory to pharmacologic and endoscopic decompression, especially those not amenable to surgical intervention due to an increased perioperative risk. Physicians are rather unfamiliar with this approach given the limited number of reports in the literature and paucity of guideline resources, although guidelines concerning ACPO and covering the role of endoscopy were recently published by three major expert societies, all within the last 2 years.
We retrospectively identified three consecutive patients who underwent PEC placement at a Czech tertiary referral center between May 2018 and December 2021: all for recurrent ACPO. In addition, we summarized the current guidelines in order to present the latest knowledge related both to the procedure and management approach in patients with ACPO.
The placement of PEC was successful and resulted in clinical improvement in all cases without any adverse events.
The results of our experience are in line with previous reports and suggest that PEC may become a very useful tool in the armamentarium of modalities utilized to treat ACPO. Furthermore, the availability of guideline resources now offers comprehensive guidance for informed decision-making and the procedural aspects.
We retrospectively identified three consecutive patients who underwent PEC placement at a Czech tertiary referral center between May 2018 and December 2021: all for recurrent ACPO. In addition, we summarized the current guidelines in order to present the latest knowledge related both to the procedure and management approach in patients with ACPO.
The placement of PEC was successful and resulted in clinical improvement in all cases without any adverse events.
The results of our experience are in line with previous reports and suggest that PEC may become a very useful tool in the armamentarium of modalities utilized to treat ACPO. Furthermore, the availability of guideline resources now offers comprehensive guidance for informed decision-making and the procedural aspects.
摘要：
背景：经皮内镜下盲肠造口术（PEC）是持续性或复发性急性结肠假性梗阻（ACPO；Ogilvie’s综合征）患者的可行治疗选择。通常应考虑在药物和内窥镜减压难以治疗的患者中，尤其是那些由于围手术期风险增加而无法接受手术干预的患者.鉴于文献中的报告数量有限且指南资源匮乏，内科医生对这种方法相当不熟悉。尽管最近由三个主要的专家协会发布了有关ACPO和涵盖内窥镜检查作用的指南，都在过去的两年里。
方法：我们回顾性地确定了在2018年5月至2021年12月期间在捷克三级转诊中心接受PEC安置的三名连续患者：均为复发性ACPO。此外,我们总结了目前的指南,以介绍与ACPO患者的操作和管理方法相关的最新知识.
结果：在所有病例中，PEC的放置是成功的，并导致临床改善，没有任何不良事件。
结论：我们的经验结果与以前的报告一致，表明PEC可能成为治疗ACPO的方法中非常有用的工具。此外，指南资源的可用性现在为知情决策和程序方面提供了全面的指导。
方法：我们回顾性地确定了在2018年5月至2021年12月期间在捷克三级转诊中心接受PEC安置的三名连续患者：均为复发性ACPO。此外,我们总结了目前的指南,以介绍与ACPO患者的操作和管理方法相关的最新知识.
结果：在所有病例中，PEC的放置是成功的，并导致临床改善，没有任何不良事件。
结论：我们的经验结果与以前的报告一致，表明PEC可能成为治疗ACPO的方法中非常有用的工具。此外，指南资源的可用性现在为知情决策和程序方面提供了全面的指导。
